Factor Xa or thrombin: Is thrombin a better target?
- 1 July 2007
- journal article
- editorial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (s1) , 65-67
- https://doi.org/10.1111/j.1538-7836.2007.02552.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial FibrillationStroke, 2007
- Anticoagulants and Cancer SurvivalSeminars in Thrombosis and Hemostasis, 2006
- The status of new anticoagulantsBritish Journal of Haematology, 2006
- A Cell-Based Model of Thrombin GenerationSeminars in Thrombosis and Hemostasis, 2006
- Fibrinogen and fibrin structure and functionsJournal of Thrombosis and Haemostasis, 2005
- Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein ThrombosisJAMA, 2005
- The Pharmacology and Management of the Vitamin K AntagonistsChest, 2004
- Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor XimelagatranNew England Journal of Medicine, 2003
- What is all that thrombin for?Journal of Thrombosis and Haemostasis, 2003
- Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trialThe Lancet, 1999